Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amyloid beta-Protein Precursor | 13 | 2023 | 1110 | 1.790 |
Why?
|
Ferritins | 5 | 2020 | 598 | 1.480 |
Why?
|
Iron-Regulatory Proteins | 2 | 2020 | 30 | 1.380 |
Why?
|
5' Untranslated Regions | 11 | 2020 | 255 | 1.350 |
Why?
|
Protein Biosynthesis | 13 | 2023 | 2104 | 1.200 |
Why?
|
alpha-Synuclein | 5 | 2020 | 749 | 1.190 |
Why?
|
Manganese | 2 | 2024 | 395 | 0.900 |
Why?
|
Iron | 11 | 2023 | 1786 | 0.830 |
Why?
|
Manganese Poisoning | 2 | 2019 | 13 | 0.820 |
Why?
|
Response Elements | 4 | 2019 | 308 | 0.770 |
Why?
|
Transcription Factor AP-1 | 2 | 2016 | 321 | 0.740 |
Why?
|
Lead Poisoning, Nervous System | 1 | 2019 | 12 | 0.660 |
Why?
|
Quinuclidines | 1 | 2019 | 24 | 0.660 |
Why?
|
Muscarinic Agonists | 1 | 2019 | 91 | 0.640 |
Why?
|
Neurodegenerative Diseases | 3 | 2020 | 1084 | 0.620 |
Why?
|
Neuroblastoma | 2 | 2024 | 1252 | 0.600 |
Why?
|
Neuroprotective Agents | 2 | 2024 | 961 | 0.590 |
Why?
|
Interleukin-1beta | 2 | 2016 | 999 | 0.550 |
Why?
|
Alzheimer Disease | 12 | 2023 | 8561 | 0.540 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 734 | 0.490 |
Why?
|
Enterocytes | 1 | 2016 | 220 | 0.470 |
Why?
|
Thiophenes | 1 | 2019 | 587 | 0.470 |
Why?
|
Interleukin-6 | 2 | 2016 | 3215 | 0.410 |
Why?
|
Amyloid beta-Peptides | 5 | 2023 | 3841 | 0.410 |
Why?
|
Interleukin-1 | 7 | 2008 | 1249 | 0.410 |
Why?
|
Neurotoxicity Syndromes | 1 | 2016 | 299 | 0.410 |
Why?
|
Lead | 1 | 2016 | 880 | 0.360 |
Why?
|
Growth Hormone | 3 | 1999 | 568 | 0.360 |
Why?
|
Alcoholism | 1 | 2020 | 1961 | 0.340 |
Why?
|
Neurons | 7 | 2020 | 9424 | 0.330 |
Why?
|
Parkinson Disease | 2 | 2020 | 2859 | 0.300 |
Why?
|
I-kappa B Proteins | 1 | 2008 | 212 | 0.290 |
Why?
|
Homeostasis | 2 | 2016 | 3306 | 0.290 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2008 | 2864 | 0.250 |
Why?
|
Iron Regulatory Protein 1 | 2 | 2013 | 37 | 0.200 |
Why?
|
Transcription, Genetic | 4 | 2000 | 7593 | 0.180 |
Why?
|
Lewy Bodies | 1 | 2020 | 144 | 0.180 |
Why?
|
RNA, Messenger | 12 | 2019 | 12762 | 0.180 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2000 | 370 | 0.170 |
Why?
|
Oxidative Stress | 2 | 2018 | 3106 | 0.160 |
Why?
|
Apoferritins | 1 | 2018 | 16 | 0.160 |
Why?
|
Cell Survival | 4 | 2024 | 5797 | 0.160 |
Why?
|
HSP70 Heat-Shock Proteins | 2 | 1999 | 397 | 0.150 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1999 | 356 | 0.140 |
Why?
|
Deferoxamine | 2 | 2016 | 153 | 0.140 |
Why?
|
Lysosomes | 1 | 2023 | 920 | 0.140 |
Why?
|
Caenorhabditis elegans Proteins | 2 | 2000 | 866 | 0.140 |
Why?
|
Horses | 2 | 1997 | 298 | 0.140 |
Why?
|
Iron Chelating Agents | 2 | 2016 | 138 | 0.140 |
Why?
|
Gene Expression Regulation | 7 | 2020 | 11902 | 0.140 |
Why?
|
DNA-Binding Proteins | 3 | 2000 | 9591 | 0.140 |
Why?
|
Epitope Mapping | 1 | 1997 | 297 | 0.140 |
Why?
|
S-Adenosylmethionine | 1 | 2018 | 213 | 0.130 |
Why?
|
Protein Precursors | 2 | 1999 | 1134 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2016 | 74 | 0.130 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2016 | 444 | 0.130 |
Why?
|
Prolactin | 2 | 1997 | 621 | 0.130 |
Why?
|
Epitopes | 2 | 1999 | 2503 | 0.120 |
Why?
|
Phosphorylation | 3 | 2016 | 8311 | 0.120 |
Why?
|
MAP Kinase Signaling System | 1 | 2000 | 1483 | 0.110 |
Why?
|
Organ Culture Techniques | 1 | 2016 | 796 | 0.110 |
Why?
|
Cognition Disorders | 1 | 2007 | 3976 | 0.110 |
Why?
|
Radioimmunoassay | 1 | 1994 | 865 | 0.110 |
Why?
|
Transcription Factors | 5 | 2016 | 12102 | 0.110 |
Why?
|
Molecular Sequence Data | 8 | 2013 | 17624 | 0.110 |
Why?
|
Down Syndrome | 2 | 2019 | 892 | 0.110 |
Why?
|
Cell Line, Tumor | 6 | 2024 | 16932 | 0.100 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 687 | 0.100 |
Why?
|
Cell Line | 7 | 2018 | 15620 | 0.100 |
Why?
|
Animals | 17 | 2022 | 167960 | 0.100 |
Why?
|
Dicloxacillin | 1 | 2011 | 9 | 0.100 |
Why?
|
Strophanthidin | 1 | 2011 | 15 | 0.100 |
Why?
|
Cardenolides | 1 | 2011 | 17 | 0.100 |
Why?
|
Environmental Pollutants | 1 | 2020 | 1265 | 0.090 |
Why?
|
Humans | 30 | 2024 | 760613 | 0.090 |
Why?
|
Mice, SCID | 1 | 2016 | 2627 | 0.090 |
Why?
|
Receptors, Opioid, delta | 1 | 2010 | 48 | 0.090 |
Why?
|
Bipolar Disorder | 1 | 2007 | 5078 | 0.090 |
Why?
|
Base Sequence | 7 | 2013 | 12444 | 0.090 |
Why?
|
Rats | 5 | 2019 | 23709 | 0.090 |
Why?
|
Intelligence | 2 | 2020 | 919 | 0.080 |
Why?
|
Chelating Agents | 2 | 2008 | 384 | 0.080 |
Why?
|
DNA | 2 | 2000 | 7233 | 0.080 |
Why?
|
Receptors, Opioid, mu | 1 | 2010 | 166 | 0.080 |
Why?
|
Child Development | 1 | 2020 | 2285 | 0.080 |
Why?
|
Signal Transduction | 5 | 2018 | 23374 | 0.080 |
Why?
|
Nucleic Acid Conformation | 2 | 2010 | 899 | 0.080 |
Why?
|
Consensus Sequence | 2 | 2000 | 365 | 0.080 |
Why?
|
Neurofibrillary Tangles | 1 | 2011 | 457 | 0.080 |
Why?
|
NF-kappa B | 2 | 2016 | 2486 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7268 | 0.080 |
Why?
|
Caco-2 Cells | 1 | 2008 | 368 | 0.070 |
Why?
|
Mice | 11 | 2022 | 81209 | 0.070 |
Why?
|
Receptors, Transferrin | 1 | 2008 | 291 | 0.070 |
Why?
|
Promoter Regions, Genetic | 3 | 2008 | 5782 | 0.070 |
Why?
|
Intestines | 1 | 2016 | 1907 | 0.070 |
Why?
|
MicroRNAs | 1 | 2022 | 3787 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2008 | 2448 | 0.070 |
Why?
|
Cross Reactions | 2 | 1999 | 818 | 0.070 |
Why?
|
Morphine | 1 | 2010 | 655 | 0.070 |
Why?
|
Environmental Exposure | 1 | 2020 | 4412 | 0.060 |
Why?
|
Transfection | 6 | 2006 | 5781 | 0.060 |
Why?
|
Repressor Proteins | 1 | 1996 | 2982 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1997 | 4356 | 0.060 |
Why?
|
Verbal Learning | 1 | 2007 | 462 | 0.060 |
Why?
|
Problem Solving | 1 | 2007 | 440 | 0.060 |
Why?
|
ADAM Proteins | 1 | 2006 | 240 | 0.060 |
Why?
|
Brain | 4 | 2020 | 26951 | 0.060 |
Why?
|
Heat-Shock Proteins | 2 | 1999 | 795 | 0.060 |
Why?
|
Antibodies, Monoclonal | 2 | 1999 | 9185 | 0.060 |
Why?
|
Multiprotein Complexes | 1 | 2010 | 1120 | 0.060 |
Why?
|
Mutation | 1 | 2008 | 29957 | 0.060 |
Why?
|
Tumor Cells, Cultured | 5 | 2002 | 6130 | 0.050 |
Why?
|
Amino Acid Sequence | 3 | 2000 | 13451 | 0.050 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2003 | 189 | 0.050 |
Why?
|
Amyloid Precursor Protein Secretases | 2 | 2022 | 619 | 0.050 |
Why?
|
Antibodies | 1 | 2010 | 2421 | 0.050 |
Why?
|
Biotin | 1 | 2022 | 253 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2825 | 0.050 |
Why?
|
Peptide Fragments | 3 | 1999 | 5132 | 0.050 |
Why?
|
Astrocytes | 2 | 2006 | 1337 | 0.040 |
Why?
|
Memory Disorders | 1 | 2007 | 1197 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2008 | 3725 | 0.040 |
Why?
|
Trans-Activators | 2 | 2000 | 2860 | 0.040 |
Why?
|
Rabbits | 2 | 1999 | 4773 | 0.040 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2000 | 125 | 0.040 |
Why?
|
Blotting, Western | 3 | 2013 | 5039 | 0.040 |
Why?
|
14-3-3 Proteins | 1 | 2000 | 221 | 0.040 |
Why?
|
Monocytes | 2 | 1999 | 2575 | 0.040 |
Why?
|
Protein Modification, Translational | 1 | 2018 | 21 | 0.040 |
Why?
|
Insulinoma | 1 | 1999 | 121 | 0.040 |
Why?
|
Blotting, Northern | 2 | 1999 | 1543 | 0.040 |
Why?
|
Models, Biological | 2 | 2008 | 9468 | 0.040 |
Why?
|
Presenilin-1 | 1 | 2022 | 660 | 0.040 |
Why?
|
Plaque, Amyloid | 1 | 2022 | 758 | 0.040 |
Why?
|
tau Proteins | 1 | 2008 | 2095 | 0.040 |
Why?
|
Swine | 2 | 1999 | 5899 | 0.040 |
Why?
|
Placental Lactogen | 1 | 1997 | 17 | 0.040 |
Why?
|
Protein Binding | 4 | 2013 | 9335 | 0.040 |
Why?
|
Mental Disorders | 1 | 2018 | 6796 | 0.040 |
Why?
|
Heat-Shock Response | 1 | 1999 | 179 | 0.040 |
Why?
|
Luciferases | 3 | 2005 | 716 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2000 | 1693 | 0.040 |
Why?
|
Glucagon | 1 | 1999 | 532 | 0.040 |
Why?
|
Immunoglobulin Isotypes | 1 | 1997 | 158 | 0.040 |
Why?
|
Hair | 1 | 2020 | 497 | 0.030 |
Why?
|
Antibody Specificity | 1 | 1999 | 1060 | 0.030 |
Why?
|
Forkhead Transcription Factors | 2 | 2000 | 1613 | 0.030 |
Why?
|
Hybridomas | 1 | 1997 | 442 | 0.030 |
Why?
|
Immunoprecipitation | 2 | 2010 | 877 | 0.030 |
Why?
|
Genes, Reporter | 3 | 2005 | 1529 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2005 | 6538 | 0.030 |
Why?
|
Mammals | 1 | 2000 | 1131 | 0.030 |
Why?
|
Methylation | 1 | 2018 | 1081 | 0.030 |
Why?
|
3T3 Cells | 1 | 1996 | 1085 | 0.030 |
Why?
|
Sheep | 1 | 1997 | 1441 | 0.030 |
Why?
|
Neuropsychological Tests | 1 | 2007 | 7022 | 0.030 |
Why?
|
Stomach, Avian | 1 | 1994 | 1 | 0.030 |
Why?
|
Secretory Rate | 1 | 1994 | 81 | 0.030 |
Why?
|
Columbidae | 1 | 1994 | 40 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2011 | 7408 | 0.030 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 1994 | 139 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2002 | 1091 | 0.030 |
Why?
|
Cytokines | 2 | 1999 | 7344 | 0.030 |
Why?
|
Pituitary Gland, Anterior | 1 | 1994 | 142 | 0.030 |
Why?
|
Physostigmine | 1 | 2013 | 50 | 0.030 |
Why?
|
Dwarfism, Pituitary | 1 | 1994 | 39 | 0.030 |
Why?
|
Species Specificity | 1 | 1997 | 2418 | 0.030 |
Why?
|
Sequence Alignment | 1 | 1997 | 2176 | 0.030 |
Why?
|
Chloramphenicol O-Acetyltransferase | 2 | 2005 | 221 | 0.030 |
Why?
|
Growth Hormone-Releasing Hormone | 1 | 1994 | 128 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 4571 | 0.030 |
Why?
|
Mutagenesis | 1 | 1996 | 1234 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2013 | 1055 | 0.030 |
Why?
|
Mammary Glands, Animal | 1 | 1994 | 271 | 0.030 |
Why?
|
Guinea Pigs | 1 | 1994 | 1316 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2000 | 3734 | 0.020 |
Why?
|
Binding Sites | 1 | 2000 | 6048 | 0.020 |
Why?
|
Cattle | 1 | 1997 | 3847 | 0.020 |
Why?
|
Caenorhabditis elegans | 1 | 2000 | 1444 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2000 | 2418 | 0.020 |
Why?
|
Lactation | 1 | 1994 | 397 | 0.020 |
Why?
|
Protease Nexins | 1 | 2010 | 39 | 0.020 |
Why?
|
Biological Assay | 1 | 1994 | 630 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2018 | 2138 | 0.020 |
Why?
|
Age Factors | 1 | 2007 | 18413 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 1994 | 1754 | 0.020 |
Why?
|
Hot Temperature | 1 | 1997 | 1435 | 0.020 |
Why?
|
Reference Standards | 1 | 1994 | 1004 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 1999 | 2414 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2006 | 7850 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 1999 | 2282 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2013 | 18955 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 1997 | 2209 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10755 | 0.020 |
Why?
|
Cricetulus | 1 | 2010 | 815 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 1997 | 6216 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2000 | 4496 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2013 | 858 | 0.020 |
Why?
|
Aniline Compounds | 1 | 2013 | 1068 | 0.020 |
Why?
|
CHO Cells | 1 | 2010 | 1389 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8158 | 0.020 |
Why?
|
Fasting | 1 | 1994 | 1603 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 2 | 2005 | 1356 | 0.020 |
Why?
|
Models, Molecular | 1 | 1997 | 5434 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 22020 | 0.020 |
Why?
|
Cricetinae | 1 | 2010 | 2427 | 0.020 |
Why?
|
Child | 2 | 2020 | 79799 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2007 | 39262 | 0.020 |
Why?
|
Poly C | 1 | 2005 | 6 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2000 | 5795 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 6964 | 0.020 |
Why?
|
RNA, Double-Stranded | 1 | 2006 | 295 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3759 | 0.010 |
Why?
|
Pregnancy Proteins | 1 | 2005 | 222 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2006 | 687 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2010 | 2316 | 0.010 |
Why?
|
DNA Methylation | 1 | 2018 | 4372 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 10826 | 0.010 |
Why?
|
Dimercaprol | 1 | 2003 | 7 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3802 | 0.010 |
Why?
|
Oxidoreductases | 1 | 2005 | 412 | 0.010 |
Why?
|
Clioquinol | 1 | 2002 | 23 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2005 | 1229 | 0.010 |
Why?
|
Paroxetine | 1 | 2003 | 182 | 0.010 |
Why?
|
Immunoblotting | 1 | 2005 | 1649 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 1999 | 5349 | 0.010 |
Why?
|
Drug Interactions | 1 | 2006 | 1428 | 0.010 |
Why?
|
Azithromycin | 1 | 2003 | 200 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9530 | 0.010 |
Why?
|
Adenovirus E1A Proteins | 1 | 2000 | 73 | 0.010 |
Why?
|
Cytoplasm | 1 | 2005 | 1516 | 0.010 |
Why?
|
CREB-Binding Protein | 1 | 2000 | 148 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2006 | 3602 | 0.010 |
Why?
|
Ultraviolet Rays | 1 | 2005 | 1078 | 0.010 |
Why?
|
Plasmids | 1 | 2005 | 2275 | 0.010 |
Why?
|
Adolescent | 1 | 2007 | 87809 | 0.010 |
Why?
|
Magnesium | 1 | 2002 | 810 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1994 | 14661 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3800 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2003 | 1347 | 0.010 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 1999 | 366 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11070 | 0.010 |
Why?
|
DNA Primers | 1 | 2000 | 2818 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 1994 | 20080 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1999 | 1126 | 0.010 |
Why?
|
Drug Approval | 1 | 2002 | 816 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 14374 | 0.010 |
Why?
|
Adult | 1 | 2007 | 220007 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2005 | 2299 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2000 | 2145 | 0.010 |
Why?
|
Up-Regulation | 1 | 1999 | 4122 | 0.010 |
Why?
|
Liver | 1 | 2005 | 7510 | 0.010 |
Why?
|
Calcium | 1 | 2002 | 5725 | 0.010 |
Why?
|
Insulin | 1 | 2000 | 6596 | 0.000 |
Why?
|
Time Factors | 1 | 2005 | 40139 | 0.000 |
Why?
|
Female | 1 | 1994 | 391246 | 0.000 |
Why?
|
United States | 1 | 2002 | 72448 | 0.000 |
Why?
|
Concepts
(258)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_